+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomerica Inc (BMRA) - Product Pipeline Analysis, 2023 Update

  • PDF Icon

    Company Profile

  • 38 Pages
  • September 2023
  • GlobalData
  • Biomerica Inc
  • ID: 5693137
Biomerica Inc (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits are used to analyze blood, urine and fecal specimens of the patient to diagnose various diseases and medical complications. It focuses on the development of products for diabetes, gastrointestinal, food intolerances and esoteric tests by utilizing enzyme immunoassay technology. Biomerica’s diagnostic tests are used by hospitals, clinical laboratories, physician’s offices and consumers around the world. The company distributes products in Americas, Europe, Asia, and the Middle East. Biomerica is headquartered in Irvin, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biomerica Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Biomerica Inc Company Overview
  • Biomerica Inc Company Snapshot
  • Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biomerica Inc - Pipeline Analysis Overview
  • Business Description
  • Biomerica Inc - Key Facts
  • Biomerica Inc - Major Products and Services
  • Biomerica Inc Pipeline Products by Development Stage
  • Biomerica Inc Pipeline Products Overview
  • Hp+detect
  • Hp+detect Product Overview
  • InFoods - Crohn’s Disease
  • InFoods - Crohn’s Disease Product Overview
  • InFoods - Depression
  • InFoods - Depression Product Overview
  • InFoods - Dermatology
  • InFoods - Dermatology Product Overview
  • InFoods - Functional Dyspepsia
  • InFoods - Functional Dyspepsia Product Overview
  • InFoods - Gastroesophageal Reflux Disease
  • InFoods - Gastroesophageal Reflux Disease Product Overview
  • InFoods - Migraine
  • InFoods - Migraine Product Overview
  • InFoods - Ulcerative Colitis
  • InFoods - Ulcerative Colitis Product Overview
  • Rapid IgG/IgM Test - COVID-19
  • Rapid IgG/IgM Test - COVID-19 Product Overview
  • Serological ELISA Test - COVID-19
  • Serological ELISA Test - COVID-19 Product Overview
  • Biomerica Inc - Key Competitors
  • Biomerica Inc - Key Employees
  • Biomerica Inc - Key Employee Biographies
  • Biomerica Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Biomerica Inc, Recent Developments
  • Jun 21, 2023: Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
  • Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
  • Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer
  • Apr 14, 2022: Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
  • Jan 13, 2022: Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
  • Dec 16, 2021: Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
  • Oct 15, 2021: Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
  • Jan 07, 2020: Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods irritable bowel syndrome (IBS) diagnostic guided therapy clinical trial
  • Oct 16, 2019: Biomerica reports 1st quarter fiscal 2020 financials
  • Aug 30, 2019: Biomerica announces fiscal year end 2019 financial results
  • Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biomerica Inc Pipeline Products by Equipment Type
  • Biomerica Inc Pipeline Products by Indication
  • Biomerica Inc, Key Facts
  • Biomerica Inc, Major Products and Services
  • Biomerica Inc Number of Pipeline Products by Development Stage
  • Biomerica Inc Pipeline Products Summary by Development Stage
  • Hp+detect - Product Status
  • Hp+detect - Product Description
  • InFoods - Crohn’s Disease - Product Status
  • InFoods - Crohn’s Disease - Product Description
  • InFoods - Depression - Product Status
  • InFoods - Depression - Product Description
  • InFoods - Dermatology - Product Status
  • InFoods - Dermatology - Product Description
  • InFoods - Functional Dyspepsia - Product Status
  • InFoods - Functional Dyspepsia - Product Description
  • InFoods - Gastroesophageal Reflux Disease - Product Status
  • InFoods - Gastroesophageal Reflux Disease - Product Description
  • InFoods - Migraine - Product Status
  • InFoods - Migraine - Product Description
  • InFoods - Ulcerative Colitis - Product Status
  • InFoods - Ulcerative Colitis - Product Description
  • Rapid IgG/IgM Test - COVID-19 - Product Status
  • Rapid IgG/IgM Test - COVID-19 - Product Description
  • Serological ELISA Test - COVID-19 - Product Status
  • Serological ELISA Test - COVID-19 - Product Description
  • Biomerica Inc, Key Employees
  • Biomerica Inc, Key Employee Biographies
  • Biomerica Inc, Subsidiaries
  • Glossary
List of Figures
  • Biomerica Inc Pipeline Products by Equipment Type
  • Biomerica Inc Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aalto Scientific Ltd
  • BG Medicine Inc
  • ALPCO Diagnostics
  • DiscoveRx Corp
  • Alfa Scientific Designs Inc
  • Calbiotech Inc